MDT insider trading
NYSE HealthcareMedtronic plc — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Medtronic plc
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.
Company website: www.medtronic.com
MDT insider activity at a glance
FilingIQ has scored 1,244 insider transactions for MDT since Jan 26, 2015. The most recent filing in our index is dated May 1, 2026.
Across the full history, 13 open-market purchases
and 150 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on MDT insider trades is 61.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest MDT Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
13F funds holding MDT
Politicians who have traded MDT
Frequently asked
- How many insider trades does FilingIQ track for MDT?
- FilingIQ tracks 1,244 Form 4 insider transactions for MDT (Medtronic plc), covering filings from Jan 26, 2015 onwards. 35 of those were filed in the last 90 days.
- Are MDT insiders net buyers or net sellers?
- Across the full Form 4 history for MDT, 13 transactions (1%) were open-market purchases and 150 (12%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does MDT insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is MDT in?
- Medtronic plc (MDT) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $111.88B.
Methodology & sources
Every MDT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.